Vident Investment Advisory’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-133,240
| Closed | -$1.06M | – | 894 |
|
|
2020
Q3 | $1.06M | Sell |
133,240
-7,289
| -5% | -$58.2K | 0.05% | 468 |
|
|
2020
Q2 | $1.41M | Buy |
+140,529
| New | +$1.41M | 0.07% | 353 |
|
|
2019
Q2 | – | Sell |
-289,340
| Closed | -$1.24M | – | 442 |
|
|
2019
Q1 | $1.24M | Sell |
289,340
-9,510
| -3% | -$40.9K | 0.07% | 378 |
|
|
2018
Q4 | $1.72M | Buy |
298,850
+106,599
| +55% | +$613K | 0.1% | 289 |
|
|
2018
Q3 | $2.61M | Sell |
192,251
-13,450
| -7% | -$182K | 0.1% | 270 |
|
|
2018
Q2 | $2.44M | Sell |
205,701
-25,648
| -11% | -$304K | 0.1% | 283 |
|
|
2018
Q1 | $2.87M | Buy |
231,349
+61,943
| +37% | +$768K | 0.12% | 253 |
|
|
2017
Q4 | $1.13M | Sell |
169,406
-81,739
| -33% | -$546K | 0.05% | 364 |
|
|
2017
Q3 | $2.06M | Buy |
251,145
+7,610
| +3% | +$62.3K | 0.11% | 278 |
|
|
2017
Q2 | $1.09M | Buy |
243,535
+10,894
| +5% | +$48.9K | 0.09% | 313 |
|
|
2017
Q1 | $1.28M | Buy |
232,641
+38,772
| +20% | +$214K | 0.13% | 291 |
|
|
2016
Q4 | $785K | Buy |
193,869
+120,724
| +165% | +$489K | 0.1% | 294 |
|
|
2016
Q3 | $516K | Sell |
73,145
-427
| -0.6% | -$3.01K | 0.07% | 338 |
|
|
2016
Q2 | $600K | Sell |
73,572
-67,514
| -48% | -$551K | 0.08% | 357 |
|
|
2016
Q1 | $1.15K | Buy |
141,086
+65,546
| +87% | +$533 | 0.07% | 348 |
|
|
2015
Q4 | $911K | Buy |
+75,540
| New | +$911K | 0.12% | 321 |
|